Introduction: Why and When radiotherapy with iBT? When SBRT?
Historical development and current indications of Image-guided Brachytherapy
Radiotherapeutic Fundamentals of Image-guided HDR Brachytherapy
A Physicist’s View
Image-guided brachytherapy: interventional setting, technique, and peri interventional patient management
The Manual of Image-guided Brachytherapy of inner organs Image-guided Brachytherapy: Follow-up. Imaging and Clinical Management
Image-guided Brachytherapy in Oligometastasis: Criteria for Patient Selection from an Oncological Perspective
Brachytherapy of primary liver lesions
Ablation of liver metastases by brachytherapy
Liver Brachytherapy – Experience from Asia
Tolerability of interstitial brachytherapy of the liver: RILD, imaging and laboratory monitoring
Lung brachytherapy: Experience from Germany
CT-guided interstitial HDR brachytherapy for malignant lung lesions: Experience from University of California Los Angeles
Brachytherapy of renal and adrenal tumours
Image-guided HDR brachytherapy of abdominal lymph nodes, pancreatic and peritoneal neoplasms
Interventional image-guided HDR brachytherapy as a salvage treatment: exclusive or in combination with other local therapies
Adverse events in iBT and their clinical management
Radiological interventions in the age of immunotherapy, molecular diagnostics and liquid biopsy
Summary
Prof. Jens Ricke
Prof. Jens Ricke and his team invented and developed the method of interstitial brachytherapy of the lung and liver in 2002 and introduced it into clinical practice. Prof. Ricke is well-known in Germany and Europe as an expert in the field of interventional radiology. Apart from interventional radiology his areas of expertise include in particular minimally invasive oncological surgery, interdisciplinary interventional radiology, nuclear medicine (therapeutic hybrid procedures) and image-guided radiotherapy. After 12 years at the Charité Universitätsmedizin Berlin (“Campus Virchow” Klinikum), Prof. Ricke was appointed in 2006 to the chair of Radiology and Nuclear Medicine at the Otto von Guericke University of Magdeburg. In 2011 he founded the German Academy of Microtherapy, of which he is still president. He has been a member of the Scientific Advisory Board of the German Medical Association since 2014. Since 2017 Prof. Ricke has also held the chair of Radiology and been director of the Department of Radiology at the Ludwig Maximillian University hospital in Munich.
PD Dr. Konrad Mohnike
Since 2002, Dr. Konrad Mohnike has worked scientifically in the field of interstitial brachytherapy. As an interventional radiologist he is an expert in this field, performing therapeutic procedures since 2011. Initially he worked with Prof. Jens Ricke, including during his time as an assistant physician after qualifying in 2006, and from 2013 he was a senior physician at the Department of Radiology and Nuclear Medicine in Magdeburg. Dr. Mohnike is an accredited specialist in radiology and interventional radiology (both since 2012) and in nuclear medicine (since 2017). In 2016 he moved to the Diagnostic Therapeutic Center in Berlin, where he established the Department of Interventional Oncology and Radionuclide Therapy. In co operation with partner hospitals, he performs brachytherapy of the liver in a private practice. In 2020 he became Medical Director of the Diagnostic Therapeutic Center. Since 2019, Dr. Mohnike has also been on the advisory board of the Berliner Krebsgesellschaft e.V. (Berlin Cancer Society).
PD Dr. Stefanie Corradini
Dr. Stefanie Corradini is a recognised radiation oncology expert in the field of brachytherapy with a wide range of experience. Initially she worked at the University of Tübingen and joined the Department of Radiation Oncology at the Ludwig Maximillian University (LMU) in Munich in 2009. Dr. Corradini has been an accredited specialist in radiation oncology since 2014, and from 2015 she has been an attending physician at the LMU. She has worked in the field of radiation oncology for over 12 years, with a clinical focus on brachytherapy, surface-guided radiotherapy, MR-guided radiotherapy, gastrointestinal tumours, gynaecological tumours and breast cancer. Dr. Corradini has been head of the Brachytherapy unit at the LMU hospital since 2017, and of the MR-guided radiotherapy programme since 2019. Dr. Corradini is a senior lecturer at the LMU, where she holds a teaching license (venia legendi).
This book provides a comprehensive insight into this special form of image-guided interventional therapy and its indications. It begins by introducing the fundamental principles of radiotherapy, the most up-to-date guidelines and the interdisciplinary aspects of the technique and then expands to more practical aspects such as therapy planning, indications and the use of the technique for certain tumor types, including liver metastases, rare tumors, cerebral malignancies and prostate tumors.
Written and edited by pioneers in this technique, the chapter’s outline results and numerous illustrated case studies from the daily routine of daily clinical practice providing an insightful guidance to this relatively new but growing method.
This is an indispensable guide for oncologists, radiation therapists and radiologists, but also general practitioners and all other specialties, which have an oncological focus.